Biopharma Intelligence, Built to Sell.
Know the drugs in development, the companies behind them, and the events that matter—at a fraction of the cost of legacy BI tools.
Built for teams that sell to biopharma.
The Biopharma Intelligence Hub
BI Data Without the Enterprise Price Tag
Current biopharma intelligence providers charge $13,500 to $40,000+ per year—pricing out individual consultants, small firms, and lean commercial teams. Ascension OPs delivers the same pipeline intelligence, company tracking, and event monitoring at a fraction of the cost.
We aggregate data from ClinicalTrials.gov, FDA press releases, and top industry publications—then use generative AI to extract, structure, and enrich it automatically. The result: a continuously updated intelligence hub with 899+ companies, 846+ drug products, and 1,121+ trials, all linked and filterable.
Whether you're a CRO prospecting for new trial sponsors, a CDMO tracking pipeline shifts, or a market access firm monitoring approvals—Ascension OPs gives you the data you need to optimize your go-to-market motions.
Who It's For
Ascension OPs is built for any company that sells to biopharma—and needs to understand the pipeline landscape to win business. We also provide consulting services to help you integrate BI data into your Marketing and Sales motions.
CROs & CDMOs
Contract Research & Manufacturing
Know which companies are running trials, what phases they're in, and when new opportunities are emerging. Track sponsor companies, identify pipeline shifts, and prospect based on therapeutic area, modality, and trial phase.
Market Access & Consulting
Reimbursement, Pricing & Advisory Firms
Monitor drug approvals, Phase III completions, and NDA/BLA filings in real time. Understand which products are approaching market entry and align your services to the companies and therapeutic areas where demand is growing.
Agencies & Tech Vendors
Advertising, SaaS & Service Providers
Filter by company size, therapeutic focus, or pipeline activity to build targeted prospect lists. Track leadership changes and partnership announcements that signal buying intent. Export data to power your CRM and outreach.
Pharmacovigilance & Regulatory
Safety, Compliance & Quality Providers
Stay ahead of new trial starts, approval events, and safety alerts. Our platform surfaces FDA press releases and trial updates relevant to your watch list—so you can engage companies at exactly the right moment in their product lifecycle.
Automated Intelligence,
Continuously Updated
Every day, our platform searches designated data sources for new content—press releases, clinical trial updates, FDA announcements, and industry news. Generative AI parses each source and extracts structured data: companies, drugs, events, phases, indications, and therapeutic areas.
New companies are matched against 899+ existing records using intelligent entity resolution with alias support (J&J = Johnson & Johnson, BMS = Bristol Myers Squibb). New products are linked to their sponsors and enriched with mechanism of action, modality, and phase data. Duplicate detection ensures nothing is counted twice.
Market data is synced automatically—tickers, market caps, employee counts, and HQ locations. Clinical trial records pull directly from ClinicalTrials.gov with full study details. Everything flows into a single filterable dashboard you can search, sort, and export.
The result: an always-current intelligence hub that would cost $30,000+ per year from Biomedtracker or GlobalData—delivered by Ascension OPs at a price accessible to consultants, small firms, and growing teams.
Why Ascension OPs
10x More Affordable
Biomedtracker charges $13,500/yr for 2 seats. GlobalData starts at $20,000. We deliver comparable pipeline intelligence at a price that doesn't shut out small teams and solo consultants.
Always Current
Automated daily ingestion from 8+ data sources including ClinicalTrials.gov and top pharma publications. No manual data entry. No stale spreadsheets. No waiting for quarterly reports.
Sales-Ready Data
Filter by therapeutic area, phase, modality, or company size—then export directly to your CRM. Built to power go-to-market motions, not just sit in a dashboard. Salesforce integration on the roadmap.
The Cost of Biopharma Intelligence Today
Legacy providers price out the teams that need this data most
Biomedtracker: $13,500/yr for just 2 seats. $30,000 for 10 seats. Pipeline data locked behind enterprise contracts.
GlobalData starts at $20,000/yr for a single user. Adding lead/event date tracking costs another $8,000. Large orgs pay $40,000+.
The same pipeline intelligence—companies, drugs, trials, events—at a price accessible to solo consultants, small firms, and growing teams.